step1 management of patients ≥ 12 years with newly diagnosed asthma
a low-dose inhaled corticosteroid (ICS)/formoterol combination inhaler to be taken as needed for symptom relief
this is termed anti-inflammatory reliever (AIR) therapy
what is tx in patients ≥ 12 years with newly diagnosed asthma if patient presents highly symptomatic (for example, regular nocturnal waking) or with a severe exacerbation?
start treatment with low-dose MART (maintenance and reliever therapy, see below)
treat the acute symptoms as appropriate (e.g. a course of oral corticosteroids may be indicated)
step 2 management of patients ≥ 12 years with newly diagnosed asthma
a low-dose MART
MART describes using an inhaled corticosteroid (ICS)/formoterol combination inhaler for daily maintenance therapy and the relief of symptoms as needed, i.e. regularly and as required
step 3 management of patients ≥ 12 years with newly diagnosed asthma
a moderate-dose MART
step 4 management of patients ≥ 12 years with newly diagnosed asthma
check the fractional exhaled nitric oxide (FeNO) level if available, and the blood eosinophil count NICE
if either of these is raised, refer to a specialist in asthma care
if neither FeNO nor eosinophil count is raised, consider a trial of either a leukotriene receptor antagonist (LTRA) or a long-acting muscarinic receptor antagonist (LAMA) used in addition to moderate-dose MART
if control has not improved, stop the LTRA or LAMA and start a trial of the alternative medicine (LTRA or LAMA)
step 5 management of patients ≥ 12 years with newly diagnosed asthma
refer people to a specialist in asthma care when asthma is not controlled despite treatment with moderate-dose MART, and trials of an LTRA and a LAMA
Sulfonylureas - side-effects
hypoglycaemia, weight gain and hyponatraemia
meds causing hyperkalaemia
ACE inhibitors
angiotensin II receptor blockers
spironolactone
heparin
ciclosporin
amiloride
most common s/e of metformin
GI disturbance
meds causing bradycardia
verapamil
amiodarone
diltiazem
ivabradine
meds causing lethargy/drowsiness
antipsychotics
tricyclic antidepressants
beta-blockers
carbamazepine
chlorpheniramine
phenytoin
Lethargy, weight gain, cold intolerance?
Second degree heart block (Mobitz II)
an ECG shows a constant PR interval but the P wave is often not followed by a QRS complex
Second degree heart block (Mobitz I)
an ECG shows progressive prolongation of the PR interval until a dropped beat occurs
Metformin - contraindicated by
CKD (eGFR < 30ml/min/1.73m2)
Insulin - side-effects
hypoglycaemia, weight gain and lipodystrophy
COPD general mx?
COPD - 1st line mx?
a short-acting beta2-agonist (SABA) or short-acting muscarinic antagonist (SAMA)
COPD - for patients who remain breathless or have exacerbations despite using short-acting bronchodilators?
is the patient has ‘asthmatic features/features suggesting steroid responsiveness’
how do you determine whether a patient has asthmatic/steroid responsive features?
COPD mx if No asthmatic features/features suggesting steroid responsiveness
add a long-acting beta2-agonist (LABA) + long-acting muscarinic antagonist (LAMA)
if already taking a SAMA, discontinue and switch to a SABA
COPD mx if Asthmatic features/features suggesting steroid responsiveness
COPD - when is oral theophylline given?
COPD - prophylactic abx?